U.S. Percutaneous Coronary Intervention Guidelines (Revised Version 2005)

Author: Yan Hongbing, Ma Changsheng, Huo Yong
Publisher:
Publish Date: 2006-02-01
Features: This guide interprets the real-world applications of drug-eluting stents. Other highlights of this guide include: ① Revised recommendations for the use of anticoagulant drugs such as clopidogrel, low-molecular-weight heparin, and bivalirudin before, during, and after percutaneous coronary intervention (PCI); ② Added recommendations for the use of distal protection devices; ③ Described the current status of emergency PCI; ④ Added recommendations for early follow-up of left main coronary artery PCI patients; ⑤ Added strategies to ensure optimal treatment outcomes and control medical quality. In summary, the new edition of the percutaneous coronary intervention guide fully reflects the current development status of the field in the United States, serving as a guiding document for clinical practice and our Chinese colleagues to learn from.